During the past decade, Kitasato University Kitasato Institute Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kitasato University Kitasato Institute Hospital" are "Crohn's Disease" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Kitasato University Kitasato Institute Hospital" in a lesser frequency.

Most popular intervention types in "Kitasato University Kitasato Institute Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Vedolizumab IV 300 mg" (1 trials), "Vedolizumab SC" (1 trials) and "Vedolizumab SC 108 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kitasato University Kitasato Institute Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kitasato University Kitasato Institute Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kitasato University Kitasato Institute Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kitasato University Kitasato Institute Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".